PU.1 regulates Alzheimer's disease-associated genes in primary human microglia.
Justin RustenhovenAmy M SmithLeon C SmythDeidre JanssonEmma L ScotterMolly E V SwansonMiranda AalderinkNatacha CoppietersPritika NarayanRenee HandleyChris OverallThomas I H ParkPatrick SchwederPeter HeppnerMaurice A CurtisRichard L M FaullMichael DragunowPublished in: Molecular neurodegeneration (2018)
Collectively, these results suggest that attenuating PU.1 may be a valid therapeutic approach to limit microglial-mediated inflammatory responses in AD and demonstrate utility of vorinostat for this purpose.